CompanyDrug

Ocumension Therapeutics’ Zerviate Receives Marketing Approval in China for Allergic Conjunctivitis Treatment

CompanyDeals

Organon Inks Deal to Acquire Dermavant, Bolstering Dermatology Portfolio with Vtama Cream

CompanyDrug

MSD’s Keytruda Secures FDA Approval for First-Line Mesothelioma Treatment in Combination with Chemotherapy

CompanyDrug

AstraZeneca’s Fasenra Secures FDA Nod for EGPA Treatment, Strengthening Rare Disease Portfolio

CompanyDeals

Fidson Healthcare Partners with Chinese Entities to Establish Drug Plant in Nigeria

CompanyDeals

MGI Tech Joins Forces with Dasa to Enhance Precision Medicine in Brazil Through Advanced Genomic Sequencing

CompanyDrug

AstraZeneca’s Tagrisso Achieves Milestones in Phase III LAURA Study for EGFR-mutated NSCLC at ESMO 2024

CompanyDrug

Keymed Biosciences’ Stapokibart Receives First Prescription in China for IL-4Rα Targeting Therapy

CompanyDrug

Adagene’s ADG126 Shows Promising Results in Phase Ib/II Study for MSS CRC at ESMO 2024

CompanyDrug

Transcenta’s Osemitamab Combo Therapy Shows Promising Results in G/GEJ Cancer Treatment at ESMO 2024

CompanyDrug

I-Mab’s Plonmarlimab Receives Breakthrough Therapy Designation in China for R/R MAS Treatment

CompanyDeals

Altamira Therapeutics and Nuance Pharma Expand Bentrio’s Reach in Asia